{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:32:21Z","timestamp":1793064741085,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"vor","delay-in-days":98,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-63138-2","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:28:03Z","timestamp":1784604483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding subclinical heart disease and cytokine profile in cardiorheumatic care of systemic lupus erythematosus"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1836-8009","authenticated-orcid":false,"given":"Jorge Estuardo","family":"Aceituno-Melgar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-2861","authenticated-orcid":false,"given":"Juan Francisco","family":"Fritche-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7658-6146","authenticated-orcid":false,"given":"Jos\u00e9 Antonio","family":"Arias-God\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-9343","authenticated-orcid":false,"given":"Luis H.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Margarita","family":"Mej\u00eda-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"C\u00e1sares-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"M\u00e1rquez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-2888","authenticated-orcid":false,"given":"Mar\u00eda Elena","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"63138_CR1","doi-asserted-by":"publisher","unstructured":"Kaul, A. et al. Systemic lupus erythematosus. Nat. Rev. Dis. Primers. 2 https:\/\/doi.org\/10.1038\/nrdp.2016.39 (2016).","DOI":"10.1038\/nrdp.2016.39"},{"key":"63138_CR2","doi-asserted-by":"crossref","unstructured":"Tsokos, G. C. Mechanisms of Disease Systemic Lupus Erythematosus. n engl j med. (2011).","DOI":"10.1056\/NEJMra1100359"},{"key":"63138_CR3","doi-asserted-by":"publisher","unstructured":"Fanouriakis, A. et al. 2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases p. 736\u2013745 (BMJ Publishing Group, 2019). https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089","DOI":"10.1136\/annrheumdis-2019-215089"},{"issue":"1","key":"63138_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/rheumatology\/keaa267","volume":"60","author":"IEM Bultink","year":"2021","unstructured":"Bultink, I. E. M., de Vries, F., van Vollenhoven, R. F. & Lalmohamed, A. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls. Rheumatol. (United Kingdom). 60 (1), 207\u2013216. https:\/\/doi.org\/10.1093\/rheumatology\/keaa267 (2021).","journal-title":"Rheumatol. (United Kingdom)"},{"key":"63138_CR5","doi-asserted-by":"crossref","unstructured":"Riboldi, P., Gerosa, M., Luzzana, C. & Catelli, L. Heart in Autoimmune Diseases Cardiac Involvement in Systemic Autoimmune Diseases (Clinical Reviews in Allergy and Immunology, 2002).","DOI":"10.1385\/CRIAI:23:3:247"},{"key":"63138_CR6","doi-asserted-by":"crossref","unstructured":"Aceituno-Melgar, J., Fritche-Salazar, J. & Soto-Lopez, J. Valvular heart disease in autoimmune diseases in Mexico [Internet]. Mexico City; (2021). Feb Available from: https:\/\/academic.oup.com\/ehjcimaging\/article\/22\/Supplement_1\/jeaa356.071\/6131127","DOI":"10.1093\/ehjci\/jeaa356.071"},{"issue":"7","key":"63138_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10554-020-01816-6","volume":"36","author":"W Deng","year":"2020","unstructured":"Deng, W. et al. Early left ventricular remodeling and subclinical cardiac dysfunction in systemic lupus erythematosus: a three-dimensional speckle tracking study. Int. J. Cardiovasc. Imaging. 36 (7), 1227\u20131235. https:\/\/doi.org\/10.1007\/s10554-020-01816-6 (2020).","journal-title":"Int. J. Cardiovasc. Imaging"},{"issue":"4","key":"63138_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.15171\/jcvtr.2018.40","volume":"10","author":"F Nikdoust","year":"2018","unstructured":"Nikdoust, F., Bolouri, E., Tabatabaei, S. A., Goudarzvand, M. & Faezi, S. T. Early diagnosis of cardiac involvement in systemic lupus erythematosus via global longitudinal strain (GLS) by speckle tracking echocardiography. J. Cardiovasc. Thorac. Res. 10 (4), 231\u2013235. https:\/\/doi.org\/10.15171\/jcvtr.2018.40 (2018).","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"63138_CR9","unstructured":"Crozier, I. G., Li, E., Milne, M. J. & Nicholls, M. G. Cardiac Involvement in Systemic LUPUS Erythematosus Detected by Echocardiography."},{"issue":"8","key":"63138_CR10","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jcmg.2022.03.007","volume":"15","author":"K Haji","year":"2022","unstructured":"Haji, K. et al. Improving the Characterization of Stage A and B Heart Failure by Adding Global Longitudinal Strain. JACC Cardiovasc. Imaging. 15 (8), 1380\u20131387. https:\/\/doi.org\/10.1016\/j.jcmg.2022.03.007 (2022).","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"9","key":"63138_CR11","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer, M. et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 71 (9), 1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930 (2019).","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"63138_CR12","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","volume":"115","author":"KA Ammar","year":"2007","unstructured":"Ammar, K. A. et al. Prevalence and prognostic significance of heart failure stages: Application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community. Circulation 115 (12), 1563\u20131570. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.666818 (2007).","journal-title":"Circulation"},{"key":"63138_CR13","doi-asserted-by":"publisher","unstructured":"Heidenreich, P. A. et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation p. E895\u20131032 (Lippincott Williams and Wilkins, 2022). https:\/\/doi.org\/10.1161\/CIR.0000000000001063","DOI":"10.1161\/CIR.0000000000001063"},{"key":"63138_CR14","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 29(2):288\u201391. PMID: 11838846. (2002)."},{"issue":"8","key":"63138_CR15","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri, M. et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 64 (8), 2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473 (2012).","journal-title":"Arthritis Rheum."},{"issue":"1","key":"63138_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell, C. et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 32 (1), 1\u201364. https:\/\/doi.org\/10.1016\/j.echo.2018.06.004 (2019).","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"1","key":"63138_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28 (1), 1\u201339e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"63138_CR18","doi-asserted-by":"publisher","unstructured":"Doria, A. et al. Cardiac involvement in systemic lupus erythematosus. Lupus 683\u2013686. https:\/\/doi.org\/10.1191\/0961203305lu2200oa (2005).","DOI":"10.1191\/0961203305lu2200oa"},{"issue":"3","key":"63138_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B. et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur. J. Heart Fail. 23 (3), 352\u2013380. https:\/\/doi.org\/10.1002\/ejhf.2115 (2021).","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"63138_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","volume":"35","author":"JN Cohn","year":"2000","unstructured":"Cohn, J. N., Ferrari, R. & Sharpe, N. Cardiac remodeling-concepts and clinical implications: A consensus paper from an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 35 (3), 569\u2013582. https:\/\/doi.org\/10.1016\/S0735-1097(99)00630-0 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"63138_CR21","unstructured":"Ghali, J. K. et al. The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease [Internet]. (1992). Available from: http:\/\/annals.org\/pdfaccess.ashx?url=\/data\/journals\/aim\/19763\/"},{"key":"63138_CR22","doi-asserted-by":"crossref","unstructured":"Schillaci, G. et al. Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension [Internet]. (2000). Available from: http:\/\/www.hypertensionaha.org","DOI":"10.1161\/01.HYP.35.2.580"},{"issue":"7","key":"63138_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0735-1097(01)01663-1","volume":"38","author":"P Verdecchia","year":"2001","unstructured":"Verdecchia, P. et al. Left Ventricular mass and cardiovascular morbidity in essential hypertension: The MAVI study. J. Am. Coll. Cardiol. 38 (7), 1829\u20131835. https:\/\/doi.org\/10.1016\/S0735-1097(01)01663-1 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"63138_CR24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jcmg.2008.05.012","volume":"1","author":"A Verma","year":"2008","unstructured":"Verma, A. et al. Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction. The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc. Imaging. 1 (5), 582\u2013591. https:\/\/doi.org\/10.1016\/j.jcmg.2008.05.012 (2008).","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"4","key":"63138_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.106.673319","volume":"116","author":"J Pieretti","year":"2007","unstructured":"Pieretti, J. et al. Systemic lupus erythematosus predicts increased left ventricular mass. Circulation 116 (4), 419\u2013426. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.673319 (2007).","journal-title":"Circulation"},{"key":"63138_CR26","doi-asserted-by":"publisher","unstructured":"AzevedoPS, PolegatoBF, MinicucciMF, PaivaSAR & ZornoffLAM Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. Arq. Bras. Cardiol. 62\u201369. https:\/\/doi.org\/10.5935\/abc.20160005 (2016).","DOI":"10.5935\/abc.20160005"},{"issue":"11","key":"63138_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ajh.2011.143","volume":"24","author":"JN Barnes","year":"2011","unstructured":"Barnes, J. N. et al. Arterial stiffening, wave reflection, and inflammation in habitually exercising systemic lupus erythematosus patients. Am. J. Hypertens. 24 (11), 1194\u20131200. https:\/\/doi.org\/10.1038\/ajh.2011.143 (2011).","journal-title":"Am. J. Hypertens."},{"key":"63138_CR28","doi-asserted-by":"publisher","unstructured":"Vignali, D. A. A. & Kuchroo, V. K. IL-12 family cytokines: immunological playmakers. Nat. Immunol. 722\u2013728. https:\/\/doi.org\/10.1038\/ni.2366 (2012).","DOI":"10.1038\/ni.2366"},{"key":"63138_CR29","doi-asserted-by":"publisher","unstructured":"van der Heijden, T., Bot, I. & Kuiper, J. The IL-12 cytokine family in cardiovascular diseases. Cytokine 122 https:\/\/doi.org\/10.1016\/j.cyto.2017.10.010 (2019).","DOI":"10.1016\/j.cyto.2017.10.010"},{"key":"63138_CR30","doi-asserted-by":"publisher","unstructured":"Barry, S. P., Townsend, P. A., Latchman, D. S. & Stephanou, A. Role of the JAK-STAT pathway in myocardial injury. Trends Mol. Med. 82\u201389. https:\/\/doi.org\/10.1016\/j.molmed.2006.12.002 (2007).","DOI":"10.1016\/j.molmed.2006.12.002"},{"key":"63138_CR31","doi-asserted-by":"publisher","unstructured":"Shi, J. & Wei, L. Regulation of JAK\/STAT signalling by SOCS in the myocardium. Cardiovascular. Res. 345\u2013347. https:\/\/doi.org\/10.1093\/cvr\/cvs321 (2012).","DOI":"10.1093\/cvr\/cvs321"},{"key":"63138_CR32","doi-asserted-by":"crossref","unstructured":"Mascareno, E. et al. JAK\/STAT Signaling Is Associated With Cardiac Dysfunction During Ischemia and Reperfusion [Internet]. (2001). Available from: http:\/\/www.circulationaha.org","DOI":"10.1161\/01.CIR.104.3.325"},{"key":"63138_CR33","doi-asserted-by":"publisher","unstructured":"Terrell, A. M. et al. JAK\/STAT\/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock 226\u2013234. https:\/\/doi.org\/10.1097\/01.shk.0000226341.32786.b9 (2006).","DOI":"10.1097\/01.shk.0000226341.32786.b9"},{"key":"63138_CR34","doi-asserted-by":"publisher","unstructured":"Hu, X., li, J., Fu, M., Zhao, X. & Wang, W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduction and Targeted Therapy (Springer Nature, 2021). https:\/\/doi.org\/10.1038\/s41392-021-00791-1","DOI":"10.1038\/s41392-021-00791-1"},{"issue":"2","key":"63138_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4161\/jkst.20115","volume":"1","author":"R Kishore","year":"2012","unstructured":"Kishore, R. & Verma, S. K. Roles of STATs signaling in cardiovascular diseases. JAKSTAT 1 (2), 118\u2013124. https:\/\/doi.org\/10.4161\/jkst.20115 (2012).","journal-title":"JAKSTAT"},{"key":"63138_CR36","doi-asserted-by":"publisher","unstructured":"Baldini, C., Moriconi, F. R., Galimberti, S., Libby, P. & de Caterina, R. The JAK-STAT pathway: An emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. European Heart Journal. Oxford University Press; pp. 4389\u2013400. (2021). https:\/\/doi.org\/10.1093\/eurheartj\/ehab447","DOI":"10.1093\/eurheartj\/ehab447"},{"issue":"9","key":"63138_CR37","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.echo.2020.04.018","volume":"33","author":"T Gegenava","year":"2020","unstructured":"Gegenava, T. et al. Left Ventricular Systolic Function in Patients with Systemic Lupus Erythematosus and Its Association with Cardiovascular Events. J. Am. Soc. Echocardiogr. 33 (9), 1116\u20131122. https:\/\/doi.org\/10.1016\/j.echo.2020.04.018 (2020).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"63138_CR38","doi-asserted-by":"publisher","unstructured":"Khanna, S., Bhat, A., Thomas, L., Arnott, C. & Nerlekar, N. Current evidence for diagnosis and management of cardiac vasculitis. Heart heartjnl-2025-327506 https:\/\/doi.org\/10.1136\/heartjnl-2025-327506 (2026). Epub ahead of print.","DOI":"10.1136\/heartjnl-2025-327506"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63138-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63138-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63138-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:09Z","timestamp":1793061309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63138-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63138"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63138-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Consent obtained directly from patient(s).","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Committee of Instituto Nacional de Cardiologia Ignacio Chavez and all subjects provided written informed consent (approval number 22-1292). Research was carried out in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"34442"}}